FAAH and Alzheimer disease: In this context, the selective pharmacological inhibition of FAAH and MAGL or dual inhibition of FAAH/MAGL—with the following increase in anandamide and 2-AG—promotes a reduction in Aβ-protein deposition in an AD rodent’s model.